A medicine can look simple from the outside: a syringe, an IV bag, a vial in a clinic refrigerator. Inside, some of the most advanced treatments in use today are anything but simple. Many are made from living cells, not mixed from basic chemicals. That makes them powerful, complex, and often expensive. That is where biosimilar medicines come in. These treatments are designed to match existing biologic drugs so closely that patients can expect the same safety and effectiveness

A promising drug can take years to move from a lab idea to an approved therapy. Many candidates fail late, after huge investments of time, money, and patient effort. That is the core problem AI is starting to change. Artificial intelligence is not replacing chemists, clinicians, biostatisticians, or regulators. Its real value is more practical. AI can scan chemical space faster than humans, find patterns in clinical data, identify patients who may respond to a therapy, and fl

A drug product is only as reliable as the active ingredient inside it. Before an active pharmaceutical ingredient, or API, can move into formulation, release, stability studies, or commercial production, it must be tested with methods that can prove identity, strength, purity, and consistency. High-performance liquid chromatography, better known as HPLC, is one of the most trusted tools for that work. It separates compounds in a liquid sample, measures them with high sensitiv